Suchergebnisse - "Herrington, W G"

PubPharm (13)

1

Effects of empagliflozin on progression of chronic kidney disease : a prespecified secondary analysis from the empa-kidney trial

enthalten in: The lancet. Diabetes & endocrinology | 2024

von EMPA-KIDNEY Collaborative Group | Staplin, N. | Haynes, R. | +98

ErratumIn: Lancet Diabetes Endocrinol. 2024 Jan 29;:. - PMID 38301677

2

Feasibility of Telemonitoring Blood Pressure in Patients With Kidney Disease (Oxford Heart and Renal Protection Study-1) : Observational Study

enthalten in: JMIR cardio | 2018

von Warner, B. | Velardo, C. | Salvi, D. | +4

3

Sex-specific relevance of diabetes to occlusive vascular and other mortality : a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

enthalten in: The lancet. Diabetes & endocrinology | 2018

von Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration | Gnatiuc, L. | Herrington, W. | +98

CommentIn: Lancet Diabetes Endocrinol. 2018 Jul;6(7):517-519. - PMID 29752193

4

Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease : United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2017

von UK HARP-III Collaborative Group | Judge, P. | Haynes, R. | +38

5

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease : results from the Study of Heart and Renal Protection

enthalten in: BMC nephrology | 2017

von Reith, C. | Staplin, N. | Herrington, W. | +12

6

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

enthalten in: BMC nephrology | 2017

von Reith, C. | Staplin, N. | Herrington, W. | +11

7

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

enthalten in: BMC nephrology | 2017

von Reith, C. | Staplin, N. | Herrington, W. | +11

8

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study) : a randomised trial

enthalten in: Lancet (London, England) | 2014

von 3C Study Collaborative Group | Haynes, R. | Harden, P. | +106

CommentIn: Lancet. 2014 Nov 8;384(9955):1649-51. - PMID 25078307

9

Acute pulmonary oedema with normal left ventricular function in a patient with resistant hypertension--what is the likely diagnosis?

enthalten in: Acute medicine | 2014

von Jones, Q. | Herrington, W.

10

Metformin use in chronic kidney disease : new evidence to guide dosing

enthalten in: QJM : monthly journal of the Association of Physicians | 2013

von Herrington, W. | Nye, H. | Aung, T.